Toronto Dominion Bank Has $27.52 Million Stock Holdings in MetLife, Inc. (NYSE:MET)

Toronto Dominion Bank raised its stake in MetLife, Inc. (NYSE:MET - Free Report) by 6.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 336,124 shares of the financial services provider's stock after buying an additional 19,307 shares during the quarter. Toronto Dominion Bank's holdings in MetLife were worth $27,521,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. United Asset Strategies Inc. increased its stake in shares of MetLife by 1.1% in the 4th quarter. United Asset Strategies Inc. now owns 10,933 shares of the financial services provider's stock valued at $895,000 after acquiring an additional 120 shares during the last quarter. Barrett & Company Inc. increased its stake in MetLife by 1.0% in the fourth quarter. Barrett & Company Inc. now owns 11,942 shares of the financial services provider's stock valued at $978,000 after purchasing an additional 121 shares in the last quarter. Eagle Strategies LLC raised its holdings in MetLife by 4.8% in the fourth quarter. Eagle Strategies LLC now owns 2,707 shares of the financial services provider's stock worth $222,000 after purchasing an additional 123 shares during the period. J.W. Cole Advisors Inc. grew its holdings in shares of MetLife by 2.1% in the 4th quarter. J.W. Cole Advisors Inc. now owns 6,044 shares of the financial services provider's stock valued at $495,000 after buying an additional 126 shares during the period. Finally, Davis R M Inc. grew its holdings in shares of MetLife by 4.2% in the 4th quarter. Davis R M Inc. now owns 3,148 shares of the financial services provider's stock valued at $258,000 after buying an additional 127 shares during the period. Hedge funds and other institutional investors own 94.99% of the company's stock.

Wall Street Analysts Forecast Growth

MET has been the topic of several research analyst reports. Piper Sandler raised their price objective on MetLife from $92.00 to $94.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. UBS Group boosted their price objective on MetLife from $94.00 to $98.00 and gave the company a "buy" rating in a research report on Wednesday, April 2nd. Wall Street Zen raised MetLife from a "hold" rating to a "buy" rating in a research note on Monday, May 5th. BMO Capital Markets assumed coverage on shares of MetLife in a research note on Thursday, January 23rd. They issued a "market perform" rating and a $97.00 price target on the stock. Finally, Morgan Stanley increased their price objective on shares of MetLife from $94.00 to $99.00 and gave the stock an "overweight" rating in a research report on Monday. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. According to MarketBeat, MetLife presently has an average rating of "Moderate Buy" and a consensus target price of $93.08.

MetLife Stock Down 0.4%

Shares of MetLife stock traded down $0.30 during trading hours on Thursday, reaching $77.60. 2,410,198 shares of the company's stock were exchanged, compared to its average volume of 3,402,162. The stock has a market cap of $52.09 billion, a P/E ratio of 13.00, a P/E/G ratio of 0.65 and a beta of 0.85. The company has a 50 day moving average of $77.07 and a two-hundred day moving average of $81.13. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $89.05.

MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.96 EPS for the quarter, missing the consensus estimate of $2.00 by ($0.04). The company had revenue of $18.57 billion for the quarter, compared to analyst estimates of $18.06 billion. MetLife had a net margin of 6.19% and a return on equity of 20.42%. The business's revenue for the quarter was up 15.6% on a year-over-year basis. During the same period last year, the company posted $1.83 earnings per share. On average, sell-side analysts forecast that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 10th. Investors of record on Tuesday, May 6th will be issued a dividend of $0.5675 per share. This represents a $2.27 dividend on an annualized basis and a yield of 2.93%. This is an increase from MetLife's previous quarterly dividend of $0.55. The ex-dividend date of this dividend is Tuesday, May 6th. MetLife's payout ratio is presently 36.91%.

MetLife declared that its Board of Directors has approved a share repurchase plan on Wednesday, April 30th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to buy up to 5.9% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's board of directors believes its stock is undervalued.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.